Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01952236 · ClinicalTrials.gov registry record · NA
Web and Mobile Smoking Cessation
A NA study, sponsored by Oregon Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 1,266
- Enrollment target
NCT01952236: Completed NA study, sponsored by Oregon Research Institute.
NCT01952236 is a NA study that has completed, run by Oregon Research Institute. The registered enrollment target is 1,266 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01952236, a NA study, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,266 participants
- Enrollment target
Study Summary
This study seeks to develop and then perform a controlled efficacy Randomized Controlled Trial assessing tobacco abstinence of a best-practices Web-based PC-delivered smoking cessation intervention (QuitOnline) compared to a Mobile Smartphone-delivered intervention (MobileQuit). Study participants are randomized to one of two conditions: a Web Only intervention and the Web+Mobile intervention. The hypothesis is that the Web+Mobile approach will yield greater efficacy than the Web Only condition.
Primary Outcome
Change in all-tobacco abstinence from enrollment to 3 and 6 months. Measured using 7 day point prevalence.
Interventions
- BEHAVIORAL Web Only
- BEHAVIORAL Web+Mobile
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,266 participants |
| Start Date | 2015-02 |
| Est. Completion | 2018-08-31 |
| Phase | NA |
What the finished NCT01952236 record still lists
NCT01952236 is an interventional study that assigns participants to a tested intervention. Its 1,266 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% lower).
The record links to 0 conditions, and to 2 interventions - of which Web Only is the first listed.
NCT01952236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01952236 about?
NCT01952236 is a clinical study titled "Web and Mobile Smoking Cessation". This study seeks to develop and then perform a controlled efficacy Randomized Controlled Trial assessing tobacco abstinence of a best-practices Web-based PC-delivered smoking cessation intervention (QuitOnline) compared to a Mobile Smartphone-delivered intervention (MobileQuit). Study participants a...
What is the current status of trial NCT01952236?
This trial is currently completed. It is a NA study. The enrollment target is 1,266 participants. The study started on 2015-02. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT01952236?
The interventions under investigation include: Web Only (BEHAVIORAL), Web+Mobile (BEHAVIORAL).
Who is sponsoring clinical trial NCT01952236?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01952236's enrollment target sits among peer trials
1,266 79th of 2000 higher than 1,922 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06119581 · 1,264 participants · Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- NCT06790641 · 1,270 participants · NA
Pathways to Perinatal Mental Health Equity
- NCT06876246 · 1,270 participants · NA
SBIR/ STTR Family Check-up Online
- NCT06712316 · 1,260 participants · Phase 2
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia